- Report
- January 2021
- 40 Pages
Global
From €3823EUR$4,000USD£3,252GBP
- Report
- February 2022
- 216 Pages
Global
From €5017EUR$5,250USD£4,269GBP
- Report
- June 2022
- 225 Pages
Global
From €4730EUR$4,950USD£4,025GBP
- Report
- October 2021
- 182 Pages
Global
From €4730EUR$4,950USD£4,025GBP
- Report
- July 2019
- 194 Pages
Global
From €1314EUR$1,375USD£1,118GBP
€2628EUR$2,750USD£2,236GBP
- Report
- March 2023
- 134 Pages
Global
From €5686EUR$5,950USD£4,838GBP
- Report
- January 2022
- 115 Pages
Global
From €5686EUR$5,950USD£4,838GBP
- Report
- October 2021
- 61 Pages
Global
From €4730EUR$4,950USD£4,025GBP
- Report
- November 2022
- 120 Pages
Global
From €2389EUR$2,500USD£2,033GBP
- Report
- April 2022
- 120 Pages
Global
From €2389EUR$2,500USD£2,033GBP
- Report
- May 2023
- 60 Pages
Global
From €4730EUR$4,950USD£4,025GBP
- Report
- September 2019
- 15 Pages
Global
- Report
- August 2022
- 330 Pages
Global
From €3044EUR$3,185USD£2,590GBP
€4348EUR$4,550USD£3,700GBP
- Report
- April 2023
- 100 Pages
Global
From €4539EUR$4,750USD£3,862GBP
- Report
- April 2023
- 112 Pages
Global
From €4539EUR$4,750USD£3,862GBP
- Report
- January 2024
- 79 Pages
From €2375EUR$2,485USD£2,021GBP
€3393EUR$3,550USD£2,887GBP
- Report
- January 2023
- 188 Pages
North America
From €2007EUR$2,100USD£1,708GBP
€2867EUR$3,000USD£2,439GBP
- Report
- December 2022
- 189 Pages
Middle East, Africa
From €2007EUR$2,100USD£1,708GBP
€2867EUR$3,000USD£2,439GBP
- Report
- December 2022
- 202 Pages
Europe
From €2007EUR$2,100USD£1,708GBP
€2867EUR$3,000USD£2,439GBP
- Report
- December 2022
- 204 Pages
Asia Pacific
From €2007EUR$2,100USD£1,708GBP
€2867EUR$3,000USD£2,439GBP
The Neurological Disorder market is a subset of the Neurology field, which focuses on the diagnosis and treatment of disorders of the nervous system. This includes conditions such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, epilepsy, and stroke. The market is composed of a variety of stakeholders, including pharmaceutical companies, medical device manufacturers, healthcare providers, and research institutions.
The market is driven by the increasing prevalence of neurological disorders, as well as advances in technology and treatments. Pharmaceutical companies are developing new drugs to treat neurological disorders, while medical device manufacturers are creating innovative products to improve patient care. Healthcare providers are also playing an important role in providing diagnosis and treatment services.
Some companies in the Neurological Disorder market include AbbVie, Biogen, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more